Inspira Technologies Oxy B.H.N. Ltd. (IINN) 10-Year Financial Performance & Capital Metrics

IINN • • Industrial / General

HealthcareMedical DevicesRespiratory & Pulmonary DevicesAirway & Pulmonary Therapy

AboutInspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.Show more

Revenue $0
EBITDA $11K +100.1%
Net Income -$11K +99.9%
EPS (Diluted) -0.00 +99.9%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -0.22% +99.8%
ROIC 0.51% +100.3%
Debt/Equity 0.58 +279.1%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Healthy 5Y average net margin of 85.5%

✗Weaknesses

✗Weak Piotroski F-Score: 1/9
✗Shares diluted 53.1% in last year
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM100%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-886.27%

EPS CAGR

10Y-

5Y-

3Y-

TTM-770%

ROCE

10Y Avg-3423.28%

5Y Avg-3512.16%

3Y Avg-11.4%

Latest0.2%

Peer Comparison

Airway & Pulmonary Therapy

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
ELMDElectromed, Inc.	236.2M	28.32	32.93	16.97%	12.38%	18.32%	4.69%	0.00
XAIRBeyond Air, Inc.	13.78M	1.72	-0.12	219.67%	-6.32%	-280.24%		0.82
LUNGPulmonx Corporation	75.48M	1.83	-1.27	22.01%	-61.91%	-94.54%		0.66
AVNSAvanos Medical, Inc.	572.81M	12.34	-1.45	2.15%	-67%	-60.27%	14.47%	0.21
INGNInogen, Inc.	175.11M	6.45	-4.24	6.35%	-7.31%	-12.87%		0.11
QIPTQuipt Home Medical Corp.	157.62M	3.58	-14.92	-0.23%	-4.11%	-10.06%	16.08%	0.16
IINNInspira Technologies Oxy B.H.N. Ltd.	31.99M	0.89	-1483.33			-190.28%		0.58

Profit & Loss

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	0	0	0	-4.68M	0	0
Revenue Growth %	-	-	-	-	-	1%	-
Cost of Goods Sold+	0	76K	203K	218K	361K	406K	488K
COGS % of Revenue	-	-	-	-	-0.08%	-	-
Gross Profit+	0	-76K	-203K	-218K	-5.04M	-406K	-488K
Gross Margin %	-	-	-	-	1.08%	-	-
Gross Profit Growth %	-	-	-1.67%	-0.07%	-22.11%	0.92%	-0.2%
Operating Expenses+	39.6K	1.27M	6.27M	11.95M	14.59M	11.72M	-11.27K
OpEx % of Revenue	-	-	-	-	-3.12%	-	-
Selling, General & Admin	13.2K	359K	2.44M	9.35M	6.72M	4.69M	4.82M
SG&A % of Revenue	-	-	-	-	-1.44%	-	-
Research & Development	26.4K	887K	3.87M	3.91M	8.05M	7.03M	6.32K
R&D % of Revenue	-	-	-	-	-1.72%	-	-
Other Operating Expenses	0	25K	-44K	-1.31M	-176K	0	-4.84M
Operating Income+	-39.6K	-1.27M	-6.27M	-12.17M	14.89M	-12.13M	11.27K
Operating Margin %	-	-	-	-	-3.18%	-	-
Operating Income Growth %	-	-31.1%	-3.93%	-0.94%	2.22%	-1.81%	1%
EBITDA+	0	-1.2M	-6.07M	-11.95M	15.19M	-11.73M	11.44K
EBITDA Margin %	-	-	-	-	-3.25%	-	-
EBITDA Growth %	-	-	-4.08%	-0.97%	2.27%	-1.77%	1%
D&A (Non-Cash Add-back)	39.6K	76K	203K	218K	292K	406K	171
EBIT	0	-4.57M	-7.16M	-16.94M	-14.98M	-11.28M	-11.27K
Net Interest Income+	0	-8.99K	-5K	-5K	4.5M	308K	173K
Interest Income	0	9	5	1K	4.68M	318K	173K
Interest Expense	0	9K	5K	6K	181K	10K	0
Other Income/Expense	0	-3.3M	-959K	-4.79M	-29.87M	847K	-22.32K
Pretax Income+	-39.6K	-4.58M	-7.23M	-16.95M	-14.98M	-11.29M	-11.05K
Pretax Margin %	-	-	-	-	3.2%	-	-
Income Tax+	0	0	0	6K	-6.27M	0	0
Effective Tax Rate %	1%	1%	1%	1%	0.27%	1%	1%
Net Income+	-39.6K	-4.58M	-7.23M	-16.96M	-4M	-11.29M	-11.05K
Net Margin %	-	-	-	-	0.86%	-	-
Net Income Growth %	-	-114.76%	-0.58%	-1.34%	0.76%	-1.82%	1%
Net Income (Continuing)	-39.6K	-4.58M	-7.23M	-16.96M	-4M	-11.29M	-11.05K
Discontinued Operations	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0
EPS (Diluted)+	-0.02	-0.34	-1.01	-3.20	-1.39	-0.93	-0.00
EPS Growth %	-	-15.83%	-1.97%	-2.17%	0.57%	0.33%	1%
EPS (Basic)	-0.02	-0.34	-1.01	-3.20	-1.39	-0.93	-0.00
Diluted Shares Outstanding	1.96M	13.51M	7.19M	5.31M	10.79M	12.1M	18.52M
Basic Shares Outstanding	1.96M	13.51M	7.19M	5.31M	10.79M	12.1M	18.52M
Dividend Payout Ratio	-	-	-	-	-	-	-

Balance Sheet

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	11K	182K	684K	24.51M	14.49M	7.79M	6.81M
Cash & Short-Term Investments	8K	96K	496K	23.75M	13.9M	7.36M	5.78M
Cash Only	8K	96K	496K	23.75M	6.78M	5.04M	5.11M
Short-Term Investments	0	0	0	0	7.12M	2.32M	668K
Accounts Receivable	0	51K	188K	210K	0	432K	0
Days Sales Outstanding	-	-	-	-	-	-	-
Inventory	-3K	34.95K	0	336K	-279K	0	444K
Days Inventory Outstanding	-	167.85	-	562.57	-	-	332.09
Other Current Assets	0	-34.95K	0	-213K	-6.5M	-176K	347K
Total Non-Current Assets+	0	192K	303K	1.36M	1.52M	1.52M	1.26M
Property, Plant & Equipment	0	192K	303K	1.36M	1.52M	1.52M	1.26M
Fixed Asset Turnover	-	-	-	-	-3.08x	-	-
Goodwill	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0
Total Assets+	11K	374K	987K	25.87M	16.01M	9.31M	8.07M
Asset Turnover	-	-	-	-	-0.29x	-	-
Asset Growth %	-	33%	1.64%	25.21%	-0.38%	-0.42%	-0.13%
Total Current Liabilities+	40K	4.99M	951K	4.31M	1.66M	2.98M	3.37M
Accounts Payable	0	74K	3K	93K	152K	198K	154K
Days Payables Outstanding	-	355.39	5.39	155.71	153.68	178	115.18
Short-Term Debt	0	4.68M	399K	3.5M	294K	1.76M	1.85M
Deferred Revenue (Current)	0	0	0	0	0	0	0
Other Current Liabilities	0	0	-74K	23K	82K	-290K	-277K
Current Ratio	0.28x	0.04x	0.72x	5.68x	8.72x	2.61x	2.02x
Quick Ratio	0.35x	0.03x	0.72x	5.60x	8.89x	2.61x	1.89x
Cash Conversion Cycle	-	-	-	-	-	-	-
Total Non-Current Liabilities+	0	28K	1.74M	1.2M	873K	588K	378K
Long-Term Debt	0	0	1.65M	302K	398K	588K	0
Capital Lease Obligations	0	28K	95K	900K	873K	588K	378K
Deferred Tax Liabilities	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	-398K	-588K	0
Total Liabilities	40K	5.01M	2.69M	5.52M	3.19M	3.57M	3.75M
Total Debt+	0	4.84M	2.32M	1.48M	1.46M	878K	2.51M
Net Debt	-8K	4.74M	1.82M	-22.27M	-5.33M	-4.16M	-2.6M
Debt / Equity	-	-	-	0.07x	0.11x	0.15x	0.58x
Debt / EBITDA	-	-	-	-	0.10x	-	219.18x
Net Debt / EBITDA	-	-	-	-	-0.35x	-	-227.66x
Interest Coverage	-	-141.22x	-1253.80x	-2027.83x	82.28x	-1213.30x	-
Total Equity+	-29K	-4.64M	-1.7M	20.35M	12.82M	5.74M	4.32M
Equity Growth %	-	-159.03%	0.63%	12.94%	-0.37%	-0.55%	-0.25%
Book Value per Share	-0.01	-0.34	-0.24	3.84	1.19	0.47	0.23
Total Shareholders' Equity	-29K	-4.64M	-1.7M	20.35M	13.63M	5.74M	4.32M
Common Stock	3K	3K	304K	48.94M	57.87M	61.26M	70.9M
Retained Earnings	-33K	-4.61M	-11.84M	-28.79M	-44.23M	-55.52M	-66.57M
Treasury Stock	0	0	0	0	0	0	0
Accumulated OCI	1K	-36K	-635K	210K	-1.93M	0	0
Minority Interest	0	0	0	0	0	0	0

Cash Flow

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	4.8K	-1.11M	-1.88M	-7.88M	-7.38M	-9.76M	-9.37M
Operating CF Margin %	-	-	-	-	1.58%	-	-
Operating CF Growth %	-	-232.46%	-0.69%	-3.2%	0.06%	-0.32%	0.04%
Net Income	-39.6K	-4.58M	-7.23M	-16.95M	-10.27M	-11.29M	-11.05M
Depreciation & Amortization	0	76K	203K	25K	361K	111K	171K
Stock-Based Compensation	0	3.29M	3.9M	6.7M	4.88M	1.49M	1.89M
Deferred Taxes	0	-3.29K	204K	0	0	0	0
Other Non-Cash Items	0	12.29K	701K	2.58M	-3.05M	-108K	48K
Working Capital Changes	44.4K	84K	348K	-233K	704K	41K	-432K
Change in Receivables	-3.6K	-46K	10K	-468K	29K	190K	0
Change in Inventory	0	46K	-10K	468K	-29K	0	-444K
Change in Payables	0	72K	-70K	87K	71K	46K	-44K
Cash from Investing+	0	-71K	-26K	-246K	-7.25M	4.59M	1.49M
Capital Expenditures	0	-31K	-23K	-176K	-304K	-206K	-164K
CapEx % of Revenue	-	-	-	-	-0.06%	-	-
Acquisitions	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-
Other Investing	0	-40K	-3K	-70K	175K	4.8M	1.65M
Cash from Financing+	3.6K	1.27M	2.29M	30.42M	-399K	3.45M	7.9M
Debt Issued (Net)	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-
Other Financing	3.6K	0	0	227K	0	3K	4K
Net Change in Cash	-	-	-	-	-	-	-
Free Cash Flow+	4.8K	-1.14M	-1.9M	-8.05M	-7.68M	-9.96M	-9.54M
FCF Margin %	-	-	-	-	1.64%	-	-
FCF Growth %	-	-238.92%	-0.66%	-3.24%	0.05%	-0.3%	0.04%
FCF per Share	0.00	-0.08	-0.26	-1.52	-0.71	-0.82	-0.52
FCF Conversion (FCF/Net Income)	-0.12x	0.24x	0.26x	0.46x	1.84x	0.86x	848.10x
Interest Paid	0	0	0	0	0	0	72K
Taxes Paid	0	0	0	0	0	0	0

Key Ratios

Metric	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-	-	-	-181.89%	-24.13%	-121.62%	-0.22%
Return on Invested Capital (ROIC)	-	-2978.91%	-4274.32%	-	400.21%	-200.68%	0.51%
Gross Margin	-	-	-	-	107.72%	-	-
Net Margin	-	-	-	-	85.55%	-	-
Debt / Equity	-	-	-	0.07x	0.11x	0.15x	0.58x
Interest Coverage	-	-141.22x	-1253.80x	-2027.83x	82.28x	-1213.30x	-
FCF Conversion	-0.12x	0.24x	0.26x	0.46x	1.84x	0.86x	848.10x
Revenue Growth	-	-	-	-	-	100%	-

Frequently Asked Questions

Growth & Financials

Inspira Technologies Oxy B.H.N. Ltd. (IINN) grew revenue by 0.0% over the past year. Growth has been modest.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) reported a net loss of $10.9M for fiscal year 2024.

Dividend & Returns

Inspira Technologies Oxy B.H.N. Ltd. (IINN) has a return on equity (ROE) of -0.2%. Negative ROE indicates the company is unprofitable.

Inspira Technologies Oxy B.H.N. Ltd. (IINN) generated $0.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

← Back to Screener